VRDN – viridian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Foghorn Therapeutics appoints Kristian Humer as chief financial officer [Seeking Alpha]
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN) and Encourages Investors to Contact the Firm
Form ARS Viridian Therapeutics, For: Dec 31
Form DEFA14A Viridian Therapeutics,
Form DEF 14A Viridian Therapeutics, For: Jun 17
Form 8-K Viridian Therapeutics, For: Apr 10
Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.